# Assessement of the Concordance of Genomic Alterations Between Urine and Tissue in High-Risk NMIBC Patients

> **NCT04412070** · — · TERMINATED · sponsor: **Hopital Foch** · enrollment: 20 (actual)

## Conditions studied

- Bladder Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04412070
- **Lead sponsor:** Hopital Foch
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2021-07-30
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** The target enrollment was not reached at the end of recrutement period. The presence of a concurrent therapeutic clinical trial in the same department significantly limited patient availability for this study, making further recruitment not feasible.
- **Last updated:** 2025-11-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04412070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04412070, "Assessement of the Concordance of Genomic Alterations Between Urine and Tissue in High-Risk NMIBC Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04412070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*